Please note, this is the application site for Option A of the Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing RFP. If you are interested in applying to Option B, please navigate to this link. 

Date open: 18 Nov 2024 | Deadline: 31 Jan 2025 - 11:30 AM Pacific Time

For further information about this Grand Challenges grant opportunity and how to apply, please visit the Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing challenge page. When you are ready to submit your application, click on the apply button on this page. 

For background on the Grand Challenges family of initiatives, including past challenges and awarded grants, please visit the Grand Challenges website.

If you have questions regarding your application, please email [email protected].